West Nile virus (WNV) is a mosquito-borne flavivirus related
to St. Louis encephalitis virus (SLEV), Murray Valley encephalitis
virus, Kunjin virus and Japanese B encephalitis virus. The virus
has been isolated from at least 43 species of mosquitos arond
the world, including Culex spp., Aedes spp. and
Anopheles spp. West Nile virus was first isolated from
a woman in Uganda in 1937. Since that time, it has been recognized
elsewhere in Africa, as well as in India, Pakistan, Asia, the
Middle East and Europe. Most recently, WNV appeared in the United
States in 1999. This is the first time that WNV has been recognized
in the Western Hemisphere.
- On August 23, 1999, an astute physician in Queens, NY recognized
that it was unusual to have 2 cases of febrile encephalitis at
the same time within a very small area of one neighborhood (Whitehurst).
Reporting to the NYC Health Department led them to uncover additional
cases from other area physicians. This outbreak in 1999 ultimately
involved 62 human cases, 7 deaths (primarily in elderly persons
with underlying illnesses) and seroconversion in 2.6% of the
~46,000 local Queen's population.
- These infections were initially attributed to SLEV. However,
the death of crows in the area (ultimately thousands died in
the northeastern U.S.), exotic birds at the Bronx Zoo (Chilean
flamingos, cormorants, a bald eagle and a snowy owl) and horses
on nearby Long Island (all of which are species not typically
made ill by SLEV) led to a search for a different agent, which
was ultimately shown to be WNV.
How was WNV introduced to the United States and from
where?
- Genetic and phylogenetic data suggest that the strain of
WNV in the United States is mostly closely related to a WNV strain
from the Middle East, specifically a WNV isolated from a goose
in Israel in 1998. West Nile virus may have been introduced to
the United States by several methods:
- introduction of an infected bird -- Given the requirements
for quarantine of birds brought into the United States, this
would have had to occur via illegal smuggling or trans-Atlantic
migration.
- introduction of infected mosquitos -- This could occur via
the transportaion of mosquitos on airliners or on-board trans-Atlantic
ships.
- travel by a person who was incubating the virus?
West Nile virus infection in people:
- The presentation of WNV infection in people can range from
asymptomatic infection to fatal encephalitis and may include:
- fever
- maculopapular rash
- muscle weakness
- flaccid paralysis
- seizures
- nausea and vomiting
- lymphopenia (This was a prominent finding in one group of
patients in the 1999 outbreak in NYC.)
- The viremia phase is reported to be relatively short in people
(6 days).
West Nile virus infection in horses:
- In the equine epizootic in 1999, 22 horses were affected,
with 13 deaths.
- Clinical signs of WNV infection in horses include an acute
onset of ataxia, hypermetria and weakness (often parparesis),
in some cases ascending to tetraparesis, complete recumbency
and death. Fever (possibly biphasic) occurs in some, but not
in all cases.
- It should be noted that not all horses present with the full
set of clinical signs, e.g. 2 horses initially presented in 1999
with unilateral forelimb lameness and 1 horse presented with
an apparent unilateral radial nerve paralysis.
- Other clinical signs in some animals include muscle fasiculations,
anisocoria, slow pupillary light responses, lacrimation, and
seizures.
- 6 of 8 horses in one study exhibited hypersensitivity to
touch and sound.
- Although a substantial percentage of horses infected with
WNV in the U.S. have succumbed (~17-39%), many of the surviving
horses have returned to training and do not exhibit residual
neurologic signs.
- The primary differential diagnoses in horses include equine
herpesvirus myelitis, equine encephalitis virus (EEEV, WEEV,
VEEV), rabies or equine protozoal myelitis (EPM). In fact, the
initial working diagnosis for many of the equine cases reported
in 1999 was EPM.
- During the summer of 2001, a killed-virus vaccine was conditionally
licensed for use in horses in the U.S.
WNV activity in the U.S. since 1999:
- WNV has proven that it can overwinter successfully in the
U.S. and it has spread to include a progressively wider geographic
region in 2000-2001.
- In 2000, there were 21 humans cases with 2 deaths, 60 equine
cases with 23 deaths (from MA, CT, RI, DE, NY, NJ and PA) and
4,323 wild bird cases (primarily crows and related species such
as ravens and jays).
- In 2001, the virus was detected from horses, people and/or
birds throughout the eastern U.S. (with the exceptions of NH,
WV and SC) and as far west as WI, IA, MO, AR and LA. There were
45 human cases (5 deaths), 347 equine cases (59 deaths) and 5991
birds cases, about 3/4 of which were, again, in crows.
- In 2002, WNV infections have already (as of February) been
detected in Florida.
- Public health officials now consider that WNV will henceforth
be a permanent, enzootic/endemic virus in the U.S. It has been
suggested that geographic expansion of the WNV range will also
continue, perhaps reaching as far west as the Rocky Mountains
during 2002.
References:
Acha, P.N. and B. Szyfres (Eds.). 1989. Zoonoses
and Communicable Diseases Common to Man and Animals. Pan American
Health Organization; Washington, D.C.
Anderson, J.F. et al. 1999. Isolation
of West Nile virus from mosquitoes, crows, and a Cooper's hawk
in Connecticut. Science 286:2331-2333.
Anonymous. 1999. Outbreak of West Nile-like
viral encephalitis -- New York, 1999. M.M.W.R.48:845-849.
Anonymous. 2000. Update: West Nile virus activity
-- northeastern United States, 2000. M.M.W.R.49:820-822.
Anonymous. 2001. West Nile virus in equids
in the northeastern United States in 2000. USDA APHIS VS Report,
August 2001.
Benenson, A.S. (Ed.). 1995. Control of Communicable
Diseases Manual. American Public Health Assoc.; Washington, D.C.
Briese, T., X.Y. Jia, C. Huang, L.J. Grady
and W.I. Lipkin. 1999. Identification of a Kunjin/West Nile-like
flavivirus in brains of patients with New York encephalitis. Lancet
354:1261-1262.
Cantile, C. et al. 2000. Clinical and
neuropathological features of West Nile virus equine encephalomyelitis
in Italy. Eq. Vet. J. 32:31-35.
Cunha, B.A. et al. 2000. Profound and
prolonged lymphopenia with West Nile encephalitis. Clin. Infect.
Dis. 31:1116-1117.
Davis, B.S. et al. 2001. West Nile virus
recombinant DNA vaccine protects mouse and horse from virus challenge
and expresses in vitro a noninfectious recombinant antigen that
can be used in enzyme-linked immunosorbent assays. J. Virol. 75:4040-4047.
Enserink, M. 1999. New York's lethal virus
came from Middle East, DNA suggests. Science 286:1450-1451.
Enserink, M. 2000. The enigma of West Nile.
Science 290:1482-1484.
Garmendia, A.E., H.J. VanKruiningen and R.A.
French. 2001. The West Nile virus: its recent emergence in North
America. Microbes Infect. 3:223-229.
Hubalek, Z. and J. Halouzka. 1999. West Nile
fever -- a reemerging mosquito-borne viral disease in Europe.
Emerg. Infect. Dis. 5:643-650.
Jia, X.Y. et al. 1999. Genetic analysis
of West Nile New York 1999 encephalitis virus [letter]. Lancet
354:1971-1972.
Lanciotti, R.S. et al. 1999. Origin of the
West Nile virus responsible for an outbreak of encephalitis in
the northeastern United States. Science 286:2333-2337.
Lustig, S. et al. 2000. A live attenuated
West Nile virus strain as a potential veterinary vaccine. Viral
Immunol. 13:410-410.
Monath, T.P. 1995. Flaviviruses, in: Principles
and Practice of Infectious Diseases (Eds. G.L. Mandel, J.E. Bennett
and R. Dolin), pp. 1465-1474. Churchill Livingston, Inc.; New
York, NY.
Nash, D. et al. 2001. The outbreak
of West Nile virus infection in the New York City area in 1999.
N. Eng. J. Med. 344:1807-1814.
Nolen, R.S. 1999. To catch a killer - Veterinarians
key to discovering outbreak of exotic encephalitis. J.A.V.M.A.
215:1415-1419.
Ostlund, E.N., J.E. Andresen and M. Andresen.
2000. West Nile encephalitis. Vet. Clin. N. Am.: Equine Pract.
16:427-441.
Snook, C.S. et al. 2001. West Nile virus
encephalomyelitis in eight horses. J.A.V.M.A. 218:1576-1579.